NanoHybrids Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.62M

  • Investors
  • 6

NanoHybrids General Information

Description

Developer of monodisperse gold nanoparticles intended for non-invasive detection of diseased tissue. The company's premium silica-coated gold nanoparticles are used for photoacoustic imaging and other techniques involving the use of pulsed lasers and can also be employed in photothermal therapy, optical imaging, microscopy, and other life science and material science applications, enabling clinicians to enhance diagnosis and therapy for cancer and other diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 3913 Todd Lane
  • Suite 310
  • Austin, TX 78744-1057
  • United States
+1 (512)
Primary Industry
Other Devices and Supplies
Other Industries
Other Commercial Products
Vertical(s)
Nanotechnology, TMT, Life Sciences, Oncology
Corporate Office
  • 3913 Todd Lane
  • Suite 310
  • Austin, TX 78744-1057
  • United States
+1 (512)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoHybrids Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2018 $1.62M Completed Generating Revenue
1. Accelerator/Incubator 18-Dec-2011 Completed Startup
To view NanoHybrids’s complete valuation and funding history, request access »

NanoHybrids Patents

NanoHybrids Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20180078659-A1 Methods of detecting biological activity, cellular behavior and drug delivery using encapsulated polymethine aggregates Inactive 08-Feb-2015

NanoHybrids Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NanoHybrids Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
National Eye Institute Government
National Heart, Lung, and Blood Institute Government
National Institute of Diabetes and Digestive and Kidney Diseases Government
National Science Foundation Government
You’re viewing 5 of 6 investors. Get the full list »

NanoHybrids FAQs

  • When was NanoHybrids founded?

    NanoHybrids was founded in 2009.

  • Where is NanoHybrids headquartered?

    NanoHybrids is headquartered in Austin, TX.

  • What is the size of NanoHybrids?

    NanoHybrids has 4 total employees.

  • What industry is NanoHybrids in?

    NanoHybrids’s primary industry is Other Devices and Supplies.

  • Is NanoHybrids a private or public company?

    NanoHybrids is a Private company.

  • What is NanoHybrids’s current revenue?

    The current revenue for NanoHybrids is .

  • Who are NanoHybrids’s investors?

    National Cancer Institute, National Eye Institute, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, and National Science Foundation are 5 of 6 investors who have invested in NanoHybrids.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »